The NOD1 expression in T cells could impede the colitis-associated intestinal tumorigenesis through mediating the IFN-γ signaling [59], and NOD2 could suppress the tumorigenesis of colitis-associated cancer by downregulating NF-κB and MAPK pathways with the induction of IRF4 [60]. The gene discussed is IRF4; the disease is colitis.